GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 46 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 15,980 | $46,022 | 0.00% |
| MORGAN STANLEY | 98,648 | $284,107 | 0.00% |
| Invesco Ltd. | 65,126 | $187,563 | 0.00% |
| BlackRock Inc. | 559,445 | $1,611,201 | 0.00% |
| Daiwa Securities Group Inc. | 146 | $0 | 0.00% |
| Qube Research & Technologies Ltd | 2,627 | $7,566 | 0.00% |
External links
This page lists GRACELL BIOTECHNOLOGIES INC's shareholders in Q3 2023. To view GRACELL BIOTECHNOLOGIES INC's shareholder history, click here.